Laddar...
The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo
Non-small cell lung cancer (NSCLC) accounts for about 85–90% of lung cancer cases, and is the number one killer among cancers in the U.S. The majority of lung cancer patients do not respond well to conventional chemo- and/or radio-therapeutic regimens, and have a dismal 5-year survival rate of ~15%....
Sparad:
| I publikationen: | Int J Cancer |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867242/ https://ncbi.nlm.nih.gov/pubmed/29277894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31234 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|